A detailed history of Wellington Management Group LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 3,245,798 shares of SRPT stock, worth $513 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,245,798
Holding current value
$513 Million
% of portfolio
0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $304 Million - $459 Million
3,245,798 New
3,245,798 $420 Million
Q4 2023

Feb 12, 2024

BUY
$67.31 - $124.76 $278 Million - $515 Million
4,127,610 New
4,127,610 $398 Million
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $5.61 Million - $6.76 Million
54,698 Added 1.42%
3,909,800 $474 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $98 Million - $145 Million
921,490 Added 31.41%
3,855,102 $441 Million
Q1 2023

May 12, 2023

BUY
$117.53 - $155.99 $44.6 Million - $59.2 Million
379,548 Added 14.86%
2,933,612 $404 Million
Q4 2022

Feb 13, 2023

SELL
$100.86 - $132.13 $484,632 - $634,884
-4,805 Reduced 0.19%
2,554,064 $331 Million
Q3 2022

Nov 14, 2022

SELL
$75.71 - $119.24 $15.9 Million - $25 Million
-209,992 Reduced 7.58%
2,558,869 $283 Million
Q2 2022

Aug 15, 2022

BUY
$62.69 - $88.44 $5.54 Million - $7.82 Million
88,383 Added 3.3%
2,768,861 $208 Million
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $42.5 Million - $60.9 Million
673,725 Added 33.57%
2,680,478 $209 Million
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $46.9 Million - $60.4 Million
607,291 Added 43.39%
2,006,753 $181 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $7.07 Million - $9.91 Million
-107,210 Reduced 7.12%
1,399,462 $129 Million
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $763,318 - $954,423
-11,002 Reduced 0.72%
1,506,672 $117 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $15.1 Million - $35.4 Million
209,362 Added 16.0%
1,517,674 $113 Million
Q4 2020

Feb 12, 2021

BUY
$125.56 - $178.74 $3.31 Million - $4.71 Million
26,375 Added 2.06%
1,308,312 $223 Million
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $19.2 Million - $26 Million
150,743 Added 13.33%
1,281,937 $180 Million
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $17.3 Million - $31.9 Million
185,782 Added 19.65%
1,131,194 $181 Million
Q1 2020

May 14, 2020

SELL
$82.38 - $131.64 $471,378 - $753,244
-5,722 Reduced 0.6%
945,412 $92.5 Million
Q4 2019

Feb 11, 2020

BUY
$76.53 - $135.58 $72.8 Million - $129 Million
951,134 New
951,134 $123 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.8B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.